Sanofi

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Sanofi and buy or sell other stocks, options, and ETFs commission-free!

About SNY

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. 

CEO
Paul Hudson
CEOPaul Hudson
Employees
87,994
Employees87,994
Headquarters
Paris, Ile-de-France
HeadquartersParis, Ile-de-France
Founded
1994
Founded1994
Employees
87,994
Employees87,994

SNY Key Statistics

Market cap
123.56B
Market cap123.56B
Price-Earnings ratio
21.17
Price-Earnings ratio21.17
Dividend yield
2.79%
Dividend yield2.79%
Average volume
3.07M
Average volume3.07M
High today
$49.46
High today$49.46
Low today
$48.17
Low today$48.17
Open price
$48.80
Open price$48.80
Volume
4.15M
Volume4.15M
52 Week high
$56.26
52 Week high$56.26
52 Week low
$42.63
52 Week low$42.63

SNY News

Seeking Alpha 9h
Bristol, Sanofi, Takeda gain positive CHMP recommendations

The European Medicines Agency's Committee for Medicinal Products for Human Use has issued positive opinions for treatments from Bristol-Myers Squibb (NYSE:BMY),...

Bristol, Sanofi, Takeda gain positive CHMP recommendations
Simply Wall St 1d
Sanofi India Will Pay A Dividend Of ₹117.00 - Simply Wall St

Sanofi India Limited ( ) has announced that it will pay a dividend of ₹117.00 per share on the 13th of June. The dividend yield of 2.0% is still a nice boost to...

Sanofi India Will Pay A Dividend Of ₹117.00 - Simply Wall St
Quartz 1d
Drug sales keep beating Wall Street's expectations and boosting some pharma stocks

It has been a busy week for pharma giants reporting their latest quarterly earnings and a lot of them have exceeded analysts’ estimates. HGTV's Property Brot...

Drug sales keep beating Wall Street's expectations and boosting some pharma stocks

Analyst ratings

79%

of 24 ratings
Buy
79.2%
Hold
16.7%
Sell
4.2%

More SNY News

TipRanks 1d
Sanofi SA Starts 2024 with Strong Sales Growth

Sanofi SA (SNY) has released an update. Sanofi SA reports a robust first quarter with a 7% sales growth, underpinned by successful product launches and a stron...

Benzinga 2d
Drugmaker Sanofi's Strong Dupixent And Beyfortus Vaccine Sales Propel Q1 Earnings

Loading... Loading... Thursday, Sanofi SA SNY reported first-quarter operating income of 2.8 billion euros, down 14.7% Y/Y and 4.2% on constant currency. The...

Drugmaker Sanofi's Strong Dupixent And Beyfortus Vaccine Sales Propel Q1 Earnings
Investor's Business Daily 2d
AstraZeneca, Sanofi Jump On First-Quarter Earnings; Bristol Myers Lags

In this article: AstraZeneca soundly topped analyst views while Sanofi narrowed its losses. Both stocks surged in early trade....

AstraZeneca, Sanofi Jump On First-Quarter Earnings; Bristol Myers Lags
TipRanks 2d
SNY Earnings: Sanofi Jumps on Healthy Q1 Performance - TipRanks.com - TipRanks

Sanofi (NASDAQ:SNY) shares jumped by over 5% in the early trading session today after the French healthcare major delivered a healthy performance for the first...

TipRanks 2d
Sanofi expects FY24 business EPS to remain relatively stable

Sanofi expects 2024 business EPS to remain roughly stable excluding the impact of an expected effective tax rate increase to 21% and decrease low single-digit a...

Reuters 2d
UPDATE 2-Sanofi profit slips on generic competition and currency effects

(Adds strategy background in paragraph 7, Beyfortus sales in last paragraph) By Ludwig Burger April 25 (Reuters) - Sanofi's first-quarter operating income fel...

UPDATE 2-Sanofi profit slips on generic competition and currency effects
Yahoo Finance 2d
Press Release: Sanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidance - Yahoo Finance

Sanofi - Aventis Groupe Sanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidance Paris, April 25, 2024 Sales growth of 6.7% at CER...

Press Release: Sanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidance - Yahoo Finance
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.